SCHEMBL20156407

SCHEMBL20156407

CC(C)(N)c1cc2cc(Cl)ccc2nc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 2/20 0.40
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
CUL4A Q13619 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ALOX12 P18054 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR3A P46098 3/20 0.36
HRH4 Q9H3N8 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
BACE1 P56817 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3273653 0.79 PDE3B (0.39) PIK3CGPDE3BPDE3ACUL4ARAB9A
SCHEMBL23518582 0.73 RXFP1 (0.35) PDE3BPDE3AHTR3AHRH4RXFP1
SCHEMBL17617970 0.72 LMNA (0.50) PIK3CGPDE3BPDE3ACUL4AALDH1A1
SCHEMBL21550247 0.71 PDE3B (0.39) PIK3CGPDE3BPDE3ACUL4AALDH1A1
SCHEMBL10914745 0.71 PDE3B (0.44) PIK3CGPDE3BPDE3ACUL4AALDH1A1
SCHEMBL22330374 0.70 KDM4E (0.46) ALDH1A1KDM4EMEN1LMNAMAPT
SCHEMBL12228824 0.69 NR4A2 (0.40) PIK3CGPDE3BPDE3AALDH1A1KDM4E
SCHEMBL789640 0.68 PDE3B (0.42) PIK3CGPDE3BPDE3ACUL4AALDH1A1
SCHEMBL21550243 0.68 KMT2A (0.44) PIK3CGPDE3BPDE3ACUL4AALDH1A1
SCHEMBL25587992 0.68 GRM1 (0.48) PDE3BPDE3AALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134682-A1 QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS FORMA THERAPEUTICS, INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134682-A1 QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS IDH1, IDH3A, IDH3B PIK3CG 2905/4885PDE3B 3731/4885PDE3A 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.